TABLE 1.
Characteristics of people with primary ciliary dyskinesia included in COVID-PCD study, N = 728 (Switzerland, 2022).
| Characteristics | Total, N = 728 |
|---|---|
| N (%) | |
| Age categories | |
| 0–14 years | 228 (31) |
| 15–49 years | 381 (52) |
| 50 years and above | 119 (16) |
| Sex | |
| Male | 292 (40) |
| Female | 434 (60) |
| Other | 2 (0) |
| Country | |
| United Kingdom | 145 (20) |
| United States | 128 (18) |
| Germany | 103 (14) |
| Switzerland | 48 (7) |
| Italy | 47 (7) |
| France | 42 (6) |
| Australia | 32 (4) |
| Other European countries | 123 (17) |
| Other non-European countries | 59 (8) |
| Severity of PCD | |
| Congenital heart disease | 53 (7) |
| Bronchiectasis | 453 (62) |
| FEV1 percent predicted (n = 435) | |
| >60% predicted | 209 (48) |
| <60% predicted | 226 (52) |
| Comorbidity (at baseline) | |
| Hypertension a | 38 (8) |
| Diabetes a | 13 (3) |
| Heart disease or heart failure a | 11 (2) |
| Cancer a | 6 (1) |
| Crohn’s disease or Colitis ulcerosa a | 12 (3) |
| Stroke ever a | 3 (1) |
| BMI > 30 a | 53 (11) |
| Any comorbidity a | 98 (21) |
| Fully vaccinated against COVID-19 (N = 569 b ) | |
| 0–14 year-olds | 79 (45) |
| 15–49 year-olds | 250 (88) |
| 50 years or older | 102 (94) |
PCD, primary ciliary dyskinesia; FEV1, forced exhaled volume in 1 s, BMI, body mass index.
a
Only asked in adults aged 18 years or older, N = 477.
b
Calculated among those who completed a special questionnaire on vaccines or completed vaccination information in a follow-up questionnaire.